A bipartisan group of 28 members of congress sent a letter yesterday urging the Biden administration to reconsider its December proposal to allow agencies to consider pricing in deciding whether and when to “march in” on patent rights. Four senators also submitted a letter opposing the WHO Pandemic Agreement.